Sumitomo Pharma Oncology Receives Orphan Drug Designation fo

/PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food and Drug...

Related Keywords

United States , China , Japan , Cambridge , Cambridgeshire , United Kingdom , Sumitomo Pharma , Jatinj Shah , Patricias Andrews , Prnewswire Sumitomo Pharma Oncology Inc , Sumitomo Pharma Co Ltd , Sumitomo Pharma Oncology Inc , Pharma Oncology , Orphan Drug Designation , Global Head , Sumitomo Pharma Oncology , Drug Designation , Chief Medical Officer , Private Securities Litigation Reform Act , Cleveland Clinic , Nc ,